Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 4:48 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1489–1512 of 6,229 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Weekly Assessment Clear all

Conditions: Prostate Carcinoma
Interventions: Swedish Massage Therapy (SMT), Light Touch (LT) Control, Waitlist Control (WLC); Procedure · Other
Lead sponsor: University of Utah; Other
Eligibility: 45 Years and older · Male only
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Solid Tumor
Interventions: SAIL66; Drug
Lead sponsor: Chugai Pharmaceutical; Industry
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 5
States / cities: Gilbert, Arizona • Augusta, Georgia • Charleston, South Carolina + 2 more

Conditions: Seizures, Seizures, Focal, Seizure, Partial Onset, Seizure Disorder, Partial, Seizure, Partial, Epilepsies, Partial, Epilepsy
Interventions: Zonisamide Oral Product; Drug
Lead sponsor: Azurity Pharmaceuticals; Industry
Eligibility: 1 Month to 17 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Winston-Salem, North Carolina • Memphis, Tennessee

Conditions: Diabetic Foot Ulcer
Interventions: Dermagraft, Comparator; Device · Other
Lead sponsor: Organogenesis; Industry
Eligibility: 18 Years and older
Enrollment: 314 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2000
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder
Interventions: Eculizumab, Placebo; Drug
Lead sponsor: Alexion Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 143 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 19
States / cities: Scottsdale, Arizona • Carlsbad, California • Washington D.C., District of Columbia + 15 more

Conditions: Dermatomyositis, Polymyositis
Interventions: Adrenocorticotropic Hormone Gel; Drug
Lead sponsor: Rohit Aggarwal, MD; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 2
States / cities: Great Neck, New York • Pittsburgh, Pennsylvania

Conditions: Ulcerative Colitis (UC)
Interventions: Adalimumab, Placebo; Drug · Other
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 952 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 42
States / cities: Dothan, Alabama • La Jolla, California • Wheat Ridge, Colorado + 36 more

Conditions: Autism Spectrum Disorder, Social Skills
Interventions: Animal-assisted intervention, Social skills group; Behavioral
Lead sponsor: Texas Tech University; Other
Eligibility: 11 Years to 17 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Lubbock, Texas

Conditions: Suicide
Interventions: Project Life Force, Treatment as Usual; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 89 Years
Enrollment: 294 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 2
States / cities: The Bronx, New York • Philadelphia, Pennsylvania

Conditions: NSCLC, Locally Advanced
Interventions: Cemiplimab, Fianlimab, Radiotherapy, Platinum Doublet Chemotherapy (PDC); Drug · Radiation
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Melasma
Interventions: Fluocinolone acetonide .1%, hydroquinone 4%, tretinoin .05%; Drug
Lead sponsor: Galderma R&D; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 2
States / cities: Los Angeles, California • Dallas, Texas

Conditions: Kidney Transplantation
Interventions: Alefacept, tacrolimus, basiliximab, mycophenolate mofetil, Corticosteroids; Drug
Lead sponsor: Astellas Pharma Inc; Industry
Eligibility: 18 Years and older
Enrollment: 323 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 38
States / cities: Loma Linda, California • Los Angeles, California • Sacramento, California + 28 more

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: Mobile spirometer, Device sensor, Salbutamol, Activity monitor, electronic diary card, CAT, ACT; Device · Drug · Other
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years and older
Enrollment: 194 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Danville, Pennsylvania

Conditions: Chronic Kidney Disease
Interventions: low-impact aerobic exercise, low-calorie (low-fat) diet; Behavioral · Dietary Supplement
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Diabetes Mellitus, Type 2
Interventions: warfarin plus albiglutide; Biological
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Spinal Muscular Atrophy, Neuromuscular Diseases, SMA
Interventions: taldefgrobep alfa, Placebo; Drug
Lead sponsor: Biohaven Pharmaceuticals, Inc.; Industry
Eligibility: 4 Years to 21 Years
Enrollment: 269 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 30
States / cities: Phoenix, Arizona • La Jolla, California • Los Angeles, California + 27 more

Conditions: Substance Use Disorders, HIV
Interventions: PrEP navigation + text messaging, Standard of Care, Contingency Management; Behavioral
Lead sponsor: Friends Research Institute, Inc.; Other
Eligibility: 18 Years and older · Male only
Enrollment: 152 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Chronic Heart Failure
Interventions: Telehealth Self Management (TSM), Standard of Care; Device · Other
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: East Meadow, New York

Conditions: Traumatic Brain Injury
Interventions: Aerobic Exercise (AER), Rehabilitation; Other
Lead sponsor: Centre for Neuro Skills; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 190 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Bakersfield, California

Conditions: Ocular Physiology
Interventions: Senofilcon A contact lenses (TEST), Delefilcon A contact lenses (CONTROL); Device
Lead sponsor: Johnson & Johnson Vision Care, Inc.; Industry
Eligibility: 18 Years to 39 Years
Enrollment: 67 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 6
States / cities: Longwood, Florida • Maitland, Florida • Granville, Ohio + 3 more

Conditions: Colorectal Cancer
Interventions: PainPac; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Cystitis, Interstitial
Interventions: ERICA; Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older · Female only
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Stroke
Interventions: Yoga focused on strength, flexibility, and balance; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Traumatic Brain Injury, Brain Injuries, Traumatic, Brain Injury, Chronic
Interventions: Group Lifestyle Balance for People with TBI (GLB-TBI); Behavioral
Lead sponsor: Baylor Research Institute; Other
Eligibility: 18 Years to 80 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Dallas, Texas

Search by objective public record fields.

Massage for Prostate Cancer-Related Fatigue (mPROSTATE)

A Phase 1 Study of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors

Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset Seizures

Pivotal Trial of Dermagraft(R) to Treat Diabetic Foot Ulcers

A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study)

Acthar in Treatment of Refractory Dermatomyositis and Polymyositis

Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis

Effects of Therapy Dogs on Social Behavior in Group Social Skills Instruction With Children With Autism

Group ("Project Life Force") vs. Individual Suicide Safety Planning RCT

Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer

Assessment of Atrophogenic Potential of Triple Combination Cream for Treatment of Melasma

A Study to Assess the Safety and Efficacy of Alefacept in Kidney Transplant Recipients

Sensor and Electronic Health Records (EHR) Integration Pilot Study

Dietary Intervention and Exercise Training (DIET) in Moderate to Severe Chronic Kidney Disease

A Drug Interaction Study With Albiglutide and Warfarin

A Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Participants With Spinal Muscular Atrophy

ASK-PrEP (Assistance Services Knowledge-PrEP)

Telehealth Management in HF Disparity Patients

Aerobic Exercise After Traumatic Brain Injury

Evaluation of Delefilcon A and Senofilcon A Daily Disposable Toric Soft Contact Lenses Over Two Weeks of Wear

Initial Testing of a Mobile App Pain Coping Intervention for Outpatient Oncology Settings (PainPac)

Smartphone-based Self-care Education Program for Women With Interstitial Cystitis: Educational Remote IC Aide

Strength, Flexibility, And Balance Therapy After Stroke

Scale-Up Evaluation Trial of the Diabetes Prevention Program to Improve Obesity and Cardiometabolic Health After Traumatic Brain Injury